
Janux Therapeutics, Inc.
USD16.26
+0.21 (+1.31%)
CEO
David Alan Campbell
IPO Date
2021-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.97
Prev. Close
$16.05
Day Low
$15.94
Day High
$16.30
52W Low
$12.12
52W High
$35.34
Market Cap
$0.99B
Volume
0.67M
| 28 Apr 2026 |
| Jones Trading |
| Buy |
| Buy |
| maintain |
| 20 Apr 2026 | Barclays | Overweight | Underweight | downgrade |
| 15 Apr 2026 | UBS | Buy | Neutral | downgrade |
| 27 Feb 2026 | Guggenheim | Buy | Buy | maintain |
| 27 Feb 2026 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 20 Jan 2026 | Clear Street | Buy | Hold | downgrade |
| 16 Jan 2026 | Piper Sandler | Overweight | Overweight | maintain |